Exploring Fluid Biomarkers in Diagnosis and Prognosis in Mild Traumatic Brain Injury Across the Age Spectrum

Tuesday, May 19, 2026

10:00 AM - 11:00 AM PT

Location: 213 & 214

Ideal Audience:Physicians, Researchers, Residents/Fellows, Medical Students

Course Director(s)

Chantel T. Debert, MD, MSc

Associate Professor
University of Calgary

Speaker(s)

CW

Cheryl Wellington, PhD

Professor
University of British Columbia
Sandy Shultz, PhD

Professor
Monash University

Brief Session Description : Over the past 10 years there has been an exploration of research exploring fluid biomarkers as a tool to aid in the diagnosis and prognosis of mild traumatic brain injury. We have identify a variety of fluid biomarkers that may be used to help determine determine injury and prognosticate outcomes. Though still in the research stages we are growing closer to understanding the utility of fluid biomarkers in mild traumatic brain injury care.

COI
Unless noted below there are none.
Chantel T. Debert, MD, MSc – Disclosed grant funding (Pfizer, Bristol-Myers Squibb)

Session Objectives:

Identifying the leading fluid biomarkers for diagnosis and prognosis in mild traumatic brain injury
Explore the current clinical utility of fluid biomarkers for diagnosis and prognosis in mild traumatic brain injury